Pharmaceutical co-crystals: are we there yet?

Blagden, Nicholas, Coles, S. J. and Berry, D. J. (2014) Pharmaceutical co-crystals: are we there yet? CrystEngComm, 16 (26). pp. 5753-5761. ISSN 1466-8033

Pharmaceutical co-crystals - are we there yet?

Request a copy
[img] PDF
__ddat02_staffhome_jpartridge_C4CE00127C.pdf - Whole Document
Restricted to Repository staff only

Item Type:Article
Item Status:Live Archive


In the pharmaceutical arena it is agreed that co-crystals form a vital part of the solid-state toolbox, allowing the progression of novel compounds through the development pathway to patients and improving properties in older medicines. Sadly though, few co-crystals have made it to the market in the form of a new licensed product. This displays a disconnect between research effort and end product. For some time now it has been possible to determine the formation of co-crystals, by a variety of screening and analytical means; although it is recognised that there will always be phases that sit in the 'greyer' area of the salt-co-crystal continuum. It is also possible, with limitations, to predict the formation of co-crystals in silico via energetic and structural considerations. So what are the major hurdles and missing links, and what are the key structural properties we need to study to improve the success rate? This highlight hopes to address these. © the Partner Organisations 2014.

Keywords:Co-crystals, Pharmaceutical Preparations, NotOAChecked
Subjects:B Subjects allied to Medicine > B230 Pharmacy
Divisions:College of Science > School of Pharmacy
Related URLs:
ID Code:14428
Deposited On:09 Jul 2014 14:18

Repository Staff Only: item control page